| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 09/27/2007 | US20070225358 Dimeric compounds and thier use as anti-viral agents |
| 09/27/2007 | US20070225299 Novel Combination Containing a Stimulator of Soluble Guanylate Cyclase and a Lipid-Lowering Substance |
| 09/27/2007 | US20070225221 Methods of treatment using specific binding agents of human angiopoietin-2 |
| 09/27/2007 | US20070225218 Extracellular Messengers |
| 09/27/2007 | US20070225214 Use of osteopontin for the treatment and/or prevention of neurologic diseases |
| 09/27/2007 | US20070224656 Modulation of Abeta levels by beta-secretase BACE2 |
| 09/27/2007 | US20070224290 Nutrient supplements and methods for treating autism and for preventing the onset of autism |
| 09/27/2007 | US20070224221 Botulinum toxin neurotoxic component for treating juvenile cerebral palsy |
| 09/27/2007 | US20070224166 Uses of mammalian cytokine; related reagents |
| 09/27/2007 | US20070224127 Cardiovascular disorders such as myocardial infarction, post-myocardial infarction remodeling, and congestive heart failure |
| 09/27/2007 | DE102006011747A1 Dermatologische und/oder kosmetische Zubereitungen Dermatological and / or cosmetic preparations |
| 09/27/2007 | CA2647769A1 Control of intracellular target molecule by ip3 receptor-binding protein |
| 09/27/2007 | CA2644207A1 Pharmaceutical combination composition comprising at least one pkc inhibitor and at least one jak3 kinase inhibitor for treating autoimmune disorders |
| 09/26/2007 | EP1837398A1 Drugs for diseases accompanying changes in total bile acid pool or lipid metabolism disorders and method of screening these drugs |
| 09/26/2007 | EP1837342A2 Sodium-channel alpha 1-subunit and their polypeptides and their treatment of generalised epilepsy with febrile seizures plus |
| 09/26/2007 | EP1837035A1 Therapeutic agent for chronic obstructive pulmonary disease (copd), cystic fibrosis or pulmonary hypertension |
| 09/26/2007 | EP1837034A1 Remedy for alzheimer´s disease |
| 09/26/2007 | EP1837033A1 REMEDY FOR DIABETES CONTAINING Cdk5 INHIBITOR |
| 09/26/2007 | EP1837031A1 Compositions and methods for treating diabetes |
| 09/26/2007 | EP1837025A2 Method of treating cancer using kinase inhibitors |
| 09/26/2007 | EP1836310A2 Method for producing probiotically derived compounds |
| 09/26/2007 | EP1835914A1 Sabcomeline alone or combined with a mood stabilising or antimanic agent to treat bipolar disorders |
| 09/26/2007 | EP1835903A1 Complex formulation of 3-hydroxy-3-methyl glutaryl coa reductase inhibitor and antihypertensive agent, and process for preparing same |
| 09/26/2007 | EP1835898A2 Methods for modulating tumor growth and metastasis |
| 09/26/2007 | EP1651234B1 Combination of mglur2 antagonist and ache inhibitor for treatment of acute and/or chronic neurological disorders |
| 09/26/2007 | EP1622577A4 Prevention of deficits in neurogenesis with anti-inflammatory agents |
| 09/26/2007 | EP1458708B1 Heteroaryl substituted triazole modulators of metabotropic glutamate receptor-5 |
| 09/26/2007 | EP1451153B1 Nk1 antagonists |
| 09/26/2007 | EP1418908B1 Compounds for eliminating and/or relieving anhedonia |
| 09/26/2007 | EP1417055A4 Use of copper chelators to inhibit the inactivation of protein c |
| 09/26/2007 | EP1341777B1 1-(2-m-methanesulfonamidophenylethyl)-4-(m-trifluoromethylphenyl)piperazine and pharmaceutically acceptable salts and solvates thereof and their use in the treatement of incontinence |
| 09/26/2007 | EP1228367B1 Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof |
| 09/26/2007 | EP1198239B1 METHODS EMPLOYING BACTERIAL ParD kis/ParD kid TOXIN-ANTITOXIN SYSTEM FOR KILLING EUKARYOTIC CELLS |
| 09/26/2007 | EP1194447B1 Novel potassium channels and genes encoding these potassium channels |
| 09/26/2007 | EP0937140B1 Antibody molecules which interact specifically with the active site or cleft of a target molecule |
| 09/26/2007 | CN101044247A Compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer |
| 09/26/2007 | CN101043905A Combined treatment with radiation and an epidermal growth factor receptor kinase inhibitor |
| 09/26/2007 | CN101043882A Use of peptide compounds for treating bone cancer pain, chemotherapy- and nucleoside-induced pain |
| 09/26/2007 | CN101041074A Anticancer compound including neoangiogenesis inhibitors and alkylate agent |
| 09/26/2007 | CN101040865A Sustained-released injection including antimetabolite medicine and alkylate agent |
| 09/26/2007 | CN101040858A Anticancer compound including taxanes and alkylate agent |
| 09/26/2007 | CN101040852A Sustained-released injection including platinum compound and the alkylate agent |
| 09/26/2007 | CN101040849A Nanometer micro-capsules having the same size for carrying medicine and the method of preparing the same |
| 09/26/2007 | CN101040844A Anticancer compound including alkylate agent and epothilones |
| 09/26/2007 | CN101040842A Sustained-released injection including phosphatidylinostitol 3-kinase inhibitor and platinum compound |
| 09/26/2007 | CN101040841A Anticancer compound including phosphatidylinostitol 3-kinase inhibitor and alkaloid |
| 09/26/2007 | CN101040840A Anticancer compound including taxanes and phosphatidylinostitol 3-kinase inhibitor |
| 09/26/2007 | CN101040839A Anticancer compound carrying phosphatidylinostitol 3-kinase inhibitor and the synergistic agent thereof |
| 09/26/2007 | CN101040838A Anticancer compound including phosphatidylinositol 3-kinase inhibitor and alkylate |
| 09/26/2007 | CN101040836A Anti-cancer combination including phosphatidylinositol 3-kinase inhibitor and antimetabolite medicine |
| 09/26/2007 | CN100339477C Methods and devices for tissure repair |
| 09/26/2007 | CN100339382C Phospholipid derivatives and process for the production there |
| 09/26/2007 | CN100339078C Solid drug for oral use |
| 09/26/2007 | CN100339057C Biodegradable injectable implants and related method of manufacture and use |
| 09/26/2007 | CN100339018C Nutritious compositions for detoxification and cancer prevention |
| 09/25/2007 | US7273932 Antisense oligonucleotides for fertility and menstrual cycle regulation and for chemopreventive and chemotherapeutic use |
| 09/25/2007 | US7273888 Administrating inhibitors of ornithine decarboxylase (involved with synthesis of putrescine; antiproliferative agents |
| 09/25/2007 | US7273887 Procaine, lidocaine, tetracaine or salts thereof; and a skin penetration enhancer in an anhydrous solution, and a volatile co-solvent; allows for a lesser total dosage resulting in decreased systemic toxicity. |
| 09/25/2007 | US7273869 P-(aminomethyl)phenyl-substituted pyrazoloquinoxalines, imidazoquinoxalines, triazoloquinoxalines and benzoquinoxalines, e.g., N,N-dimethyl-1-[4-(6-phenyl-1H-imidazo[4,5-g]quinoxalin-7-yl)phenyl]methanamine; serine/threonine protein kinase inhibitors for treating cancer |
| 09/25/2007 | US7273853 6-11 bicyclic ketolide derivatives |
| 09/25/2007 | US7273751 Comprises nucleotide sequences associated with expression vector coding endothelial growth factor for use in diagnosis and treatment of tumor angiogenesis, inflammation, diabetic retinopathy, arthritis and psoriasis; wound healing agent |
| 09/25/2007 | US7273744 Heparanase-like polypeptides |
| 09/25/2007 | US7273712 Methods and compositions for detecting compounds that modulate inflammatory responses |
| 09/25/2007 | US7273698 Defects in periaxin associated with myelinopathies |
| 09/25/2007 | US7273623 Complex containing tannin; solid dosage form; sustained release |
| 09/25/2007 | US7273609 Methods for treating autoimmune and chronic inflammatory conditions using antagonists of CD30 or CD30L |
| 09/25/2007 | US7273607 Comprises vitamins, minerals, amino acids, herbs, and essential oils; side effect reduction |
| 09/25/2007 | US7273606 Solubilized CoQ-10 and carnitine |
| 09/25/2007 | US7273604 Fine dry powder; rapidly spreads and melts over lung and air passageway surfaces |
| 09/25/2007 | CA2387502C Multiwell scanner and scanning method |
| 09/25/2007 | CA2301183C Pharmacologic drug combination in vagal-induced asystole |
| 09/25/2007 | CA2288650C A method for the treatment of mental illness in mammals and a composition therefor |
| 09/25/2007 | CA2215692C Method of modulating microcirculation |
| 09/20/2007 | WO2007106723A2 Pharmaceutical formulations comprising polyanionic materials and zinc-based preservatives |
| 09/20/2007 | WO2007106432A2 Egf receptor phosphorylation status for disease treatment |
| 09/20/2007 | WO2007106264A2 Extended cycle multiphasic oral contraceptive method |
| 09/20/2007 | WO2007105621A1 Cardiac dysfunction-ameliorating agent or cardiac function-maintaining agent |
| 09/20/2007 | WO2007105551A1 Novel pyridine derivative having anti-helicobacter pylori activity |
| 09/20/2007 | WO2007105442A1 Therapeutic agent for food intake disorder or water intake disorder |
| 09/20/2007 | WO2007104143A1 METHODS FOR DIAGNOSIS AND PROGNOSIS OF GRAFT VERSUS HOST DISEASE BY MEASUREMENT OF PERIPHERAL CD3+CD4+CD8β+ CELLS |
| 09/20/2007 | WO2007075554A3 Combination of igfr inhibitor and anti-cancer agent |
| 09/20/2007 | WO2007030581A3 Neuroprotectants |
| 09/20/2007 | WO2007016185A3 Mono-and bi-functional antibody conjugates as effective adjuvants of protein vaccination |
| 09/20/2007 | WO2006136175A3 Pharmaceutical compositions comprising tacrolimus and a cyp3a4 inhibitor |
| 09/20/2007 | WO2006081371A3 Combination therapy with triterpenoid compounds and proteasome inhibitors |
| 09/20/2007 | US20070219271 Pharmaceutical Compositions Containing Pufa And At Least One Of An Immunosuppressive Agent Or An Antineoplastic Agent |
| 09/20/2007 | US20070219264 inhibiting rejection of a transplanted organ, tissue or cell in a recipient mammal; immunosuppressive agent; autoimmune diseases |
| 09/20/2007 | US20070219177 Agent for treatment of cerebral ischemic diseases |
| 09/20/2007 | US20070219175 Controlled Release Pharmaceutical Composition Comprising An Acid-Insoluble And A Bioadhesive Polymer |
| 09/20/2007 | US20070219157 Complete nutrient medium for use as a cosmetic and cosmetic use thereof |
| 09/20/2007 | US20070219150 Nerve Cell Differentiation Inducer |
| 09/20/2007 | US20070219142 Composition Comprising a Diuretic and/or Cardiac Glycosed for the Treatment of Dna Viral Infections of the Eye |
| 09/20/2007 | US20070218511 Methods for the diagnosis and treatment of lung cancer |
| 09/20/2007 | US20070218129 Solid Dispersible and/or Orodispersible Non-Filmy Containing at Least One Type of Active Substance Pharmaceutical Composition and Method for the Preparation Thereof |
| 09/20/2007 | US20070218114 Soluble Strip for Oral or Topical Administration |
| 09/20/2007 | US20070218106 Alcohol Metabolism Moderating Composition |
| 09/20/2007 | US20070218056 Methods for identification, diagnosis, and treatment of breast cancer |
| 09/20/2007 | US20070218031 Candidate drug which inhibits the interaction between AICD and p53 in neurons is selected as a drug for the prevention and/or treatment of Alzheimer's disease; provides treatment of Alzheimer's disease based on a different Alzheimer's disease onset mechanism from the amyloid hypothesis |
| 09/20/2007 | US20070218026 DNA encoding the human serine protease EOS |
| 09/20/2007 | US20070218013 Aerosolized Fosfomycin/Aminoglycoside Combination for the Treatment of Bacterial Respiratory Infections |